HLB LifeScience
Gyeongju
About HLB LifeScience
HLB LifeScience is a research-oriented global target anticancer drug development biotech company. They offer animal anti-cancer drug clinical and approval of pirotinib non-small cell lung cancer rare disease drug.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2016)
- Ticker: kosdaq:067630
- Website: hlb-ls.com
- Phone: 82-2-2627-6700
Industries & Categories
Biotechnology, Health Care, Life Science, Medical Device
Canonical: https://fsome.com/organization/hlb-lifescience-1941627 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.